Tirzepatide Lyophilized Peptide Powder

Our Tirzepatide Lyophilized Peptide Powder is a synthetic, modified peptide with agonist activity at both the glucose-dependent insulinotropic polypeptide (GIP) receptor and the glucagon-like peptide-1 (GLP-1) receptor. It is supplied for qualified laboratory research involving dual incretin-receptor pharmacology, peptide–receptor interactions, and associated molecular signaling pathways.

The lyophilized format is intended to support controlled laboratory handling and preparation in appropriate biochemical, analytical, and cellular research models. Tirzepatide may be used to investigate GIP and GLP-1 receptor activation, intracellular signaling, endocrine communication, and the interaction of these two receptor systems under controlled experimental conditions.

This independently supplied research material is not an FDA-approved drug product and is not intended to represent or substitute for any FDA-approved prescription product containing tirzepatide.

For Research Use Only. Not for human or veterinary use. Not for compounding, administration, diagnostic, therapeutic, clinical, or household applications.